Glucosamine 500mg Capsule Franchise in Ahmedabad

Joint Care Capsule Supplier in Bangalore

Glucosamine Capsule Distributor in Hyderabad

Osteoarthritis Support Capsule Franchise in Jaipur

Bone & Joint Health Capsule Stockist in Mumbai
Glucosamine Capsule Manufacturer & Exporter in Chandigarh

Home/Products /glucosamine-500mg-capsule

Glosap 500 Capsule

Composition : Glucosamine (500mg) Capsule

Dosage Form : Capsule

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Glosap 500 Capsule contains Glucosamine 500mg, a higher-strength joint-support ingredient essential for maintaining healthy cartilage and joint structure. It is commonly used in the management of osteoarthritis and other degenerative joint conditions.

Glucosamine plays a vital role in cartilage formation, lubrication of joints, and reducing joint stiffness. Regular use helps improve flexibility, mobility, and overall joint comfort, particularly in elderly patients and individuals with chronic joint stress.

This strength is widely prescribed by orthopedicians and rheumatologists for patients requiring enhanced joint support. Its consistent demand in orthopedic clinics, hospitals, and wellness centers makes it a reliable product in the bone and joint therapy segment.

Glosap 500 Capsule is a strong addition to any orthopedic and nutraceutical product range, offering opportunities in pharmacy sales, institutional supply, hospital procurement, export markets, and contract manufacturing. Its higher dosage and long-term usability ensure steady market acceptance.

Read More

About the Product

Glosap 500 Capsule contains Glucosamine 500mg, a higher-strength joint-support ingredient essential for maintaining healthy cartilage and joint structure. It is commonly used in the management of osteoarthritis and other degenerative joint conditions.

Glucosamine plays a vital role in cartilage formation, lubrication of joints, and reducing joint stiffness. Regular use helps improve flexibility, mobility, and overall joint comfort, particularly in elderly patients and individuals with chronic joint stress.

This strength is widely prescribed by orthopedicians and rheumatologists for patients requiring enhanced joint support. Its consistent demand in orthopedic clinics, hospitals, and wellness centers makes it a reliable product in the bone and joint therapy segment.

Glosap 500 Capsule is a strong addition to any orthopedic and nutraceutical product range, offering opportunities in pharmacy sales, institutional supply, hospital procurement, export markets, and contract manufacturing. Its higher dosage and long-term usability ensure steady market acceptance.

Some patients may experience mild gastrointestinal symptoms such as nausea, bloating, heartburn, constipation, or diarrhea. Allergic reactions are rare but may occur in individuals sensitive to shellfish-derived products.

Glosap 500 Capsule is indicated for the management of osteoarthritis, joint pain, stiffness, reduced joint mobility, and other degenerative joint disorders, particularly in elderly patients or individuals with joint wear and tear.

Use under medical supervision, especially in diabetic patients, as glucosamine may influence blood glucose levels. Not recommended for individuals with known shellfish allergy unless advised by a healthcare professional.

Store Glosap 500 Capsule in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our Successful network today.

Quick Navigation

1500+ Products

Our Divisions

All Therapeutics

Disclaimer: Pharma Insights are based on operational standards as of March 2026. All territories are subject to availability and Revised Schedule M compliance.